A meta-analysis published in 2021 [23] reported that in the DOR population, the PPOS protocol resulted in a lower incidence of early-onset luteinising hormone (LH) peaks and ovarian hyperstimulation syndrome than did the GnRH antagonist regimen, GnRH agonist regimen, and natural cycle. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.